Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
08/06

DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rallied 1.28% to $484.83 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.49% to 54,349.12 and the S&P 500 Index falling 0.17% to 7,723.55.

This was the stock's second consecutive day of gains.

Vertex Pharmaceuticals Inc. closed 9.15% below its 52-week high of $533.67, which the company achieved on July 7th.

The stock outperformed some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ rose 0.98% to $246.20, Krystal Biotech Inc. (KRYS) rose 0.31% to $325.78, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 0.64% to $6.26.

Trading volume (1.4 M) remained 243,263 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 5, 2026.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10